About the journal
Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the …
$3130
Article publishing charge
for open access
8 days
Time to first decision
54 days
Review time
79 days
Submission to acceptance
Co-Editors-in-Chief
View full editorial boardArticles
More from Translational Oncology
Calls for papers
Exploiting Synthetic Lethal Interactions in Cancer Therapy
Guest editors: Srinivasan Madhusudan - Submission deadline: 31 December 2024
DNA damage signaling response and repair (DDR) is critical for genomic stability. Pre-clinical and clinical studies confirm reduced DNA repair capacity in cells can promote cancer development. On the other hand, we also know that upregulation of …
Africa Research Special Series - from Bench to Community
Guest editors: Verna Vanderpuye, Nazik Hammad, Solomon Rotimi Submission deadline: 31 July 2024
Africa is a vast and diverse continent in many ways that affects cancer control efforts developed in other settings. These efforts may fail to translate into benefit for myriad of reasons that include health system challenges, pharmacogenomics, …
Submission deadline: 31 July 2024
Special issues and article collections
Non-genetic heterogeneity and adaptive mechanisms in cancer evolution and drug resistance
Edited by Mohit Kumar Jolly, Subhajyoti De
1 March 2024
Exploiting Synthetic Lethal interactions in cancer therapy
Edited by Prof. Dr. Srinivasan Madhusudan
19 February 2024
Print ISSN: 1944-7124
Online ISSN: 1936-5233
Copyright © 2024 Neoplasia Press Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.